Jack Ball
Director at Cytek Biosciences, Inc. (CTKB)
Jack Ball has filed 8 insider reports with the SEC since June 2022, as director at Cytek Biosciences, Inc. (CTKB). Jack Ball made no open-market purchases or sales in the last 12 months. The latest filing, on June 12, 2026, reports exercise or conversion of a derivative at Cytek Biosciences, Inc. (CTKB).
- Filings
- 8
- Companies
- 1
- Bought on market
- None
- Sold on market
- $235K
Companies where Jack Ball is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 86,678 | $235K | $6.12 | Jun 12, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 10, 2026CTKBDirector Ball Jack converted options into 43,973 shares, increasing direct ownership by 103% to 86,678 unitsForm 4Exercise or conversion of a derivative
- Jun 18, 2025CTKBSEC Form 4 filed by Director Ball JackForm 4Grant or award
- Jun 5, 2025CTKBDirector Ball Jack converted options into 15,706 shares, increasing direct ownership by 58% to 42,705 unitsForm 4Exercise or conversion of a derivative
- Jun 5, 2024CTKBSEC Form 4 filed by Ball JackForm 4Grant or award
- Jun 14, 2023CTKBSEC Form 4 filed by Ball JackForm 4Grant or award
- Nov 29, 2022CTKBSEC Form 4: Ball Jack exercised 23,999 shares at a strike of $0.69, increasing direct ownership by 800% to 26,999 unitsForm 4Exercise or conversion of a derivative
- Nov 14, 2022-$235KCTKBSEC Form 4: Ball Jack exercised 16,000 shares at a strike of $0.40 and sold $235,040 worth of shares (16,000 units at $14.69) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 1, 2022CTKBSEC Form 4 filed by Ball JackForm 4Grant or award
Compare Jack Ball with
- Jack Ball vs Ilan Feuchtwang1 shared
- Jack Ball vs Wenbin Jiang1 shared
- Jack Ball vs William D. McCombe1 shared
- Jack Ball vs Glenn P Muir1 shared
- Jack Ball vs Michael Holder1 shared
- Jack Ball vs Richard Chin1 shared
Other insiders at the same companies
- Glenn P MuirCTKB
- Michael HolderCTKB
- Ming YanCTKB
- Richard ChinCTKB
- William D. McCombeCTKB
- Wenbin JiangCTKB
- Ilan FeuchtwangCTKB
- Vera ImperCTKB
- Deborah J NeffCTKB
- Philippe BusqueCTKB
- Valerie BarnettCTKB
- Don M HardisonCTKB
Questions about Jack Ball
- What is Jack Ball's role at Cytek Biosciences, Inc.?
- Jack Ball reports to the SEC as director at Cytek Biosciences, Inc. (CTKB), according to the latest filing on June 12, 2026.
- How many shares does Jack Ball own?
- After the latest filing that states it, Jack Ball directly owned 86,678 shares of Cytek Biosciences, Inc. (CTKB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jack Ball bought or sold stock recently?
- The most recent open-market sale was on November 14, 2022: sold 16,000 shares of Cytek Biosciences, Inc. (CTKB) for $235K at an average of $14.69.
- How do I get alerts when Jack Ball files?
- Follow Jack Ball on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Jack Ball (SEC CIK 0001873083). Totals count each trade once, skipping amendments whose original is on file, from Jun 3, 2022 on. View on SEC EDGAR · Get this as JSON